{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T22:40:11Z","timestamp":1793227211424,"version":"4.5.0"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2020,2,12]],"date-time":"2020-02-12T00:00:00Z","timestamp":1581465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2020,2,12]],"date-time":"2020-02-12T00:00:00Z","timestamp":1581465600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Pharmacokinet"],"published-print":{"date-parts":[[2020,7]]},"DOI":"10.1007\/s40262-020-00861-7","type":"journal-article","created":{"date-parts":[[2020,2,12]],"date-time":"2020-02-12T06:02:40Z","timestamp":1581487360000},"page":"911-925","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":59,"title":["Integration of Placental Transfer in a Fetal\u2013Maternal Physiologically Based Pharmacokinetic Model to Characterize Acetaminophen Exposure and Metabolic Clearance in the Fetus"],"prefix":"10.1007","volume":"59","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3551-1201","authenticated-orcid":false,"given":"Paola","family":"Mian","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karel","family":"Allegaert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sigrid","family":"Conings","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pieter","family":"Annaert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dick","family":"Tibboel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Pfister","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristel","family":"van Calsteren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John N.","family":"van den Anker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andr\u00e9","family":"Dallmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,2,12]]},"reference":[{"key":"861_CR1","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1186\/s12884-015-0745-3","volume":"15","author":"FE Pisa","year":"2015","unstructured":"Pisa FE, Casetta A, Clagnan E, Michelesio E, Vecchi Brumatti L, Barbone F. Medication use during pregnancy, gestational age and date of delivery: agreement between maternal self-reports and health database information in a cohort. BMC Pregnancy Childbirth. 2015;15:310. https:\/\/doi.org\/10.1186\/s12884-015-0745-3.","journal-title":"BMC Pregnancy Childbirth."},{"issue":"8","key":"861_CR2","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1124\/dmd.117.075192","volume":"45","author":"Z Zhang","year":"2017","unstructured":"Zhang Z, Imperial MZ, Patilea-Vrana GI, Wedagedera J, Gaohua L, Unadkat JD. Development of a novel maternal-fetal physiologically based pharmacokinetic model I: insights into factors that determine fetal drug exposure through simulations and sensitivity analyses. Drug Metab Dispos. 2017;45(8):920\u201338. https:\/\/doi.org\/10.1124\/dmd.117.075192.","journal-title":"Drug Metab Dispos."},{"issue":"12","key":"861_CR3","doi-asserted-by":"publisher","first-page":"1525","DOI":"10.1007\/s40262-017-0538-0","volume":"56","author":"A Dallmann","year":"2017","unstructured":"Dallmann A, Ince I, Solodenko J, Meyer M, Willmann S, Eissing T, et al. Physiologically based pharmacokinetic modeling of renally cleared drugs in pregnant women. Clin Pharmacokinet. 2017;56(12):1525\u201341. https:\/\/doi.org\/10.1007\/s40262-017-0538-0.","journal-title":"Clin Pharmacokinet."},{"issue":"6","key":"861_CR4","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.1002\/cpt.1084","volume":"104","author":"A Dallmann","year":"2018","unstructured":"Dallmann A, Pfister M, van den Anker J, Eissing T. Physiologically based pharmacokinetic modeling in pregnancy: a systematic review of published models. Clin Pharmacol Ther. 2018;104(6):1110\u201324. https:\/\/doi.org\/10.1002\/cpt.1084.","journal-title":"Clin Pharmacol Ther."},{"issue":"5","key":"861_CR5","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1016\/j.siny.2017.07.006","volume":"22","author":"K Allegaert","year":"2017","unstructured":"Allegaert K, van den Anker JN. Perinatal and neonatal use of paracetamol for pain relief. Semin Fetal Neonatal Med. 2017;22(5):308\u201313. https:\/\/doi.org\/10.1016\/j.siny.2017.07.006.","journal-title":"Semin Fetal Neonatal Med."},{"issue":"2","key":"861_CR6","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1097\/ftd.0000000000000379","volume":"39","author":"RB Flint","year":"2017","unstructured":"Flint RB, Mian P, van der Nagel B, Slijkhuis N, Koch BC. Quantification of acetaminophen and its metabolites in plasma using UPLC-MS: doors open to therapeutic drug monitoring in special patient populations. Ther Drug Monit. 2017;39(2):164\u201371. https:\/\/doi.org\/10.1097\/ftd.0000000000000379.","journal-title":"Ther Drug Monit."},{"issue":"2","key":"861_CR7","doi-asserted-by":"publisher","first-page":"93","DOI":"10.2165\/00003088-198207020-00001","volume":"7","author":"JAH Forrest","year":"1982","unstructured":"Forrest JAH, Clements JA, Prescott LF. Clinical pharmacokinetics of paracetamol. Clin Pharmacokinet. 1982;7(2):93\u2013107.","journal-title":"Clin Pharmacokinet."},{"issue":"Suppl 2","key":"861_CR8","doi-asserted-by":"publisher","first-page":"291S","DOI":"10.1111\/j.1365-2125.1980.tb01812.x","volume":"10","author":"LF Prescott","year":"1980","unstructured":"Prescott LF. Kinetics and metabolism of paracetamol and phenacetin. Br J Clin Pharmacol. 1980;10(Suppl 2):291S\u20138S.","journal-title":"Br J Clin Pharmacol."},{"issue":"2","key":"861_CR9","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1016\/j.jaci.2014.07.065","volume":"135","author":"JE Sordillo","year":"2015","unstructured":"Sordillo JE, Scirica CV, Rifas-Shiman SL, Gillman MW, Bunyavanich S, Camargo CA, et al. Prenatal and infant exposure to acetaminophen and ibuprofen and the risk for wheeze and asthma in children. J Allergy Clin Immunol. 2015;135(2):441\u20138. https:\/\/doi.org\/10.1016\/j.jaci.2014.07.065.","journal-title":"J Allergy Clin Immunol."},{"issue":"6","key":"861_CR10","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1016\/j.jaci.2010.08.047","volume":"126","author":"SO Shaheen","year":"2010","unstructured":"Shaheen SO, Newson RB, Ring SM, Rose-Zerilli MJ, Holloway JW, Henderson AJ. Prenatal and infant acetaminophen exposure, antioxidant gene polymorphisms, and childhood asthma. J Allergy Clin Immunol. 2010;126(6):1141\u20138. https:\/\/doi.org\/10.1016\/j.jaci.2010.08.047.","journal-title":"J Allergy Clin Immunol."},{"issue":"6","key":"861_CR11","doi-asserted-by":"publisher","first-page":"1702","DOI":"10.1093\/ije\/dyt183","volume":"42","author":"RE Brandlistuen","year":"2013","unstructured":"Brandlistuen RE, Ystrom E, Nulman I, Koren G, Nordeng H. Prenatal paracetamol exposure and child neurodevelopment: a sibling-controlled cohort study. Int J Epidemiol. 2013;42(6):1702\u201313. https:\/\/doi.org\/10.1093\/ije\/dyt183.","journal-title":"Int J Epidemiol."},{"issue":"4","key":"861_CR12","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1001\/jamapediatrics.2013.4914","volume":"168","author":"Z Liew","year":"2014","unstructured":"Liew Z, Ritz B, Rebordosa C, Lee PC, Olsen J. Acetaminophen use during pregnancy, behavioral problems, and hyperkinetic disorders. JAMA Pediatr. 2014;168(4):313\u201320. https:\/\/doi.org\/10.1001\/jamapediatrics.2013.4914.","journal-title":"JAMA Pediatr."},{"issue":"1","key":"861_CR13","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1111\/bcp.13778","volume":"85","author":"K Allegaert","year":"2019","unstructured":"Allegaert K, Mian P, Lapillonne A, van den Anker JN. Maternal paracetamol intake and fetal ductus arteriosus constriction or closure: a case series analysis. Br J Clin Pharmacol. 2019;85(1):245\u201351. https:\/\/doi.org\/10.1111\/bcp.13778.","journal-title":"Br J Clin Pharmacol."},{"issue":"4","key":"861_CR14","doi-asserted-by":"publisher","first-page":"1574","DOI":"10.1172\/JCI59755","volume":"122","author":"MR McGill","year":"2012","unstructured":"McGill MR, Sharpe MR, Williams CD. The mechanism underlying acetaminophen-induced hepatotoxicity in humans and mice involves mitochondrial damage and nuclear DNA fragmentation. J Clin Investig. 2012;122(4):1574\u201383. https:\/\/doi.org\/10.1172\/JCI59755.","journal-title":"J Clin Investig."},{"issue":"4","key":"861_CR15","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1111\/bcp.12815","volume":"81","author":"Mendes M De Sousa","year":"2016","unstructured":"De Sousa Mendes M, Hirt D, Vinot C, Valade E, Lui G, Pressiat C, et al. Prediction of human fetal pharmacokinetics using ex vivo human placenta perfusion studies and physiologically based models. Br J Clin Pharmacol. 2016;81(4):646\u201357. https:\/\/doi.org\/10.1111\/bcp.12815.","journal-title":"Br J Clin Pharmacol."},{"issue":"8","key":"861_CR16","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1124\/dmd.116.073957","volume":"45","author":"Z Zhang","year":"2017","unstructured":"Zhang Z, Unadkat JD. Development of a novel maternal-fetal physiologically based pharmacokinetic model II: verification of the model for passive placental permeability drugs. Drug Metab Dispos. 2017;45(8):939\u201346. https:\/\/doi.org\/10.1124\/dmd.116.073957.","journal-title":"Drug Metab Dispos."},{"key":"861_CR17","doi-asserted-by":"publisher","DOI":"10.1007\/s40262-019-00799-5","author":"P Mian","year":"2019","unstructured":"Mian P, van den Anker JN, van Calsteren K, Annaert P, Tibboel D, Pfister M, et al. Physiologically based pharmacokinetic modeling to characterize acetaminophen pharmacokinetics and N-acetyl-p-benzoquinone imine (NAPQI) formation in non-pregnant and pregnant women. Clin Pharmacokinet. 2019 Jul 25. https:\/\/doi.org\/10.1007\/s40262-019-00799-5.","journal-title":"Clin Pharmacokinet"},{"key":"861_CR18","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.taap.2019.03.004","volume":"370","author":"S Conings","year":"2019","unstructured":"Conings S, Tseke F, Van den Broeck A, Qi B, Paulus J, Amant F, et al. Transplacental transport of paracetamol and its phase II metabolites using the ex vivo placenta perfusion model. Toxicol Appl Pharmacol. 2019;370:14\u201323. https:\/\/doi.org\/10.1016\/j.taap.2019.03.004.","journal-title":"Toxicol Appl Pharmacol."},{"issue":"6","key":"861_CR19","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1055\/s-0036-1593845","volume":"34","author":"JF Nitsche","year":"2017","unstructured":"Nitsche JF, Patil AS, Langman LJ, Penn HJ, Derleth D, Watson WJ, et al. Transplacental passage of acetaminophen in term pregnancy. Am J Perinatol. 2017;34(6):541\u20133. https:\/\/doi.org\/10.1055\/s-0036-1593845.","journal-title":"Am J Perinatol."},{"issue":"1","key":"861_CR20","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1186\/s12871-015-0144-3","volume":"15","author":"K Allegaert","year":"2015","unstructured":"Allegaert K, Peeters MY, Beleyn B, Smits A, Kulo A, van Calsteren K, et al. Paracetamol pharmacokinetics and metabolism in young women. BMC Anesthesiol. 2015;15(1):163. https:\/\/doi.org\/10.1186\/s12871-015-0144-3.","journal-title":"BMC Anesthesiol."},{"issue":"5","key":"861_CR21","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1007\/BF00191910","volume":"46","author":"L Beaulac-Baillargeon","year":"1994","unstructured":"Beaulac-Baillargeon L, Rocheleau S. Paracetamol pharmacokinetics during the first trimester. Eur J Clin Pharmacol. 1994;46(5):451\u20134.","journal-title":"Eur J Clin Pharmacol."},{"issue":"1","key":"861_CR22","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1038\/clpt.1983.127","volume":"34","author":"MC Mitchell","year":"1983","unstructured":"Mitchell MC, Hanew T, Meredith CG, Schenker S. Effects of oral contraceptive steroids on acetaminophen metabolism and elimination. Clin Pharmacol Ther. 1983;34(1):48\u201353.","journal-title":"Clin Pharmacol Ther."},{"issue":"10","key":"861_CR23","doi-asserted-by":"publisher","first-page":"e1002750","DOI":"10.1371\/journal.pcbi.1002750","volume":"8","author":"M Krauss","year":"2012","unstructured":"Krauss M, Schaller S, Borchers S, Findeisen R, Lippert J, Kuepfer L. Integrating cellular metabolism into a multiscale whole-body model. PLoS Comput Biol. 2012;8(10):e1002750. https:\/\/doi.org\/10.1371\/journal.pcbi.1002750.","journal-title":"PLoS Comput Biol."},{"issue":"3","key":"861_CR24","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1002\/bdra.20535","volume":"82","author":"AA Adjei","year":"2008","unstructured":"Adjei AA, Gaedigk A, Simon SD, Weinshilboum RM, Leeder JS. Interindividual variability in acetaminophen sulfation by human fetal liver: Implications for pharmacogenetic investigations of drug-induced birth defects. Birth Defects Res A Clin Mol Teratol. 2008;82(3):155\u201365. https:\/\/doi.org\/10.1002\/bdra.20535.","journal-title":"Birth Defects Res A Clin Mol Teratol."},{"issue":"9","key":"861_CR25","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1007\/s00228-015-1887-y","volume":"71","author":"EH Krekels","year":"2015","unstructured":"Krekels EH, van Ham S, Allegaert K, de Hoon J, Tibboel D, Danhof M, et al. Developmental changes rather than repeated administration drive paracetamol glucuronidation in neonates and infants. Eur J Clin Pharmacol. 2015;71(9):1075\u201382. https:\/\/doi.org\/10.1007\/s00228-015-1887-y.","journal-title":"Eur J Clin Pharmacol."},{"issue":"12","key":"861_CR26","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1177\/106002808401801205","volume":"18","author":"RE Galinsky","year":"1984","unstructured":"Galinsky RE, Levy G. Absorption and metabolism of acetaminophen shortly before parturition. Drug Intell Clin Pharm. 1984;18(12):977\u20139.","journal-title":"Drug Intell Clin Pharm."},{"issue":"1","key":"861_CR27","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1111\/j.1471-0528.1970.tb03405.x","volume":"77","author":"JS Davison","year":"1970","unstructured":"Davison JS, Davison MC, Hay DM. Gastric emptying time in late pregnancy and labour. J Obstet Gynaecol Br Commonw. 1970;77(1):37\u201341.","journal-title":"J Obstet Gynaecol Br Commonw."},{"key":"861_CR28","doi-asserted-by":"publisher","first-page":"437639","DOI":"10.1155\/2012\/437639","volume":"2012","author":"A Kulo","year":"2012","unstructured":"Kulo A, van Calsteren K, Verbesselt R, Smits A, Devlieger R, de Hoon J, et al. The impact of Caesarean delivery on paracetamol and ketorolac pharmacokinetics: a paired analysis. J Biomed Biotechnol. 2012;2012:437639.","journal-title":"J Biomed Biotechnol."},{"issue":"1","key":"861_CR29","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1111\/j.1365-2044.1993.tb06793.x","volume":"48","author":"EM Whitehead","year":"1993","unstructured":"Whitehead EM, Smith M, Dean Y, O\u2019Sullivan G. Forum: an evaluation of gastic emptying times in pregnancy and the puerperium. Anaesthesia. 1993;48(1):53\u20137.","journal-title":"Anaesthesia."},{"issue":"11","key":"861_CR30","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1093\/bja\/50.11.1145","volume":"50","author":"JD Holdsworth","year":"1978","unstructured":"Holdsworth JD. Relationship between stomach contents and analgesia in labour. Br J Anaesth. 1978;50(11):1145\u20138.","journal-title":"Br J Anaesth."},{"issue":"7912","key":"861_CR31","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1016\/S0140-6736(75)91687-6","volume":"1","author":"WS Nimmo","year":"1975","unstructured":"Nimmo WS, Wilson J, Prescott LF. Narcotic analgesics and delayed gastric emptying during labour. Lancet. 1975;1(7912):890\u20133.","journal-title":"Lancet."},{"key":"861_CR32","doi-asserted-by":"publisher","first-page":"CD003930","DOI":"10.1002\/14651858.CD003930.pub3","volume":"8","author":"M Singata","year":"2013","unstructured":"Singata M, Tranmer J, Gyte GM. Restricting oral fluid and food intake during labour. Cochrane Database Syst Rev. 2013;8:CD003930. https:\/\/doi.org\/10.1002\/14651858.CD003930.pub3.","journal-title":"Cochrane Database Syst Rev."},{"issue":"10","key":"861_CR33","first-page":"1433","volume":"86","author":"L Marzio","year":"1991","unstructured":"Marzio L, Formica P, Fabiani F, LaPenna D, Vecchiett L, Cuccurullo F. Influence of physical activity on gastric emptying of liquids in normal human subjects. Am J Gastroenterol. 1991;86(10):1433\u20136.","journal-title":"Am J Gastroenterol."},{"issue":"1","key":"861_CR34","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1042\/bj1960257","volume":"196","author":"N Kawade","year":"1981","unstructured":"Kawade N, Onishi S. The prenatal and postnatal development of UDP-glucuronyltransferase activity towards bilirubin and the effect of premature birth on this activity in the human liver. Biochem J. 1981;196(1):257\u201360.","journal-title":"Biochem J."},{"issue":"8","key":"861_CR35","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1203\/00006450-197808000-00007","volume":"12","author":"BF Felsher","year":"1978","unstructured":"Felsher BF, Maidman JE, Carpio NM, VanCouvering K, Woolley MM. Reduced hepatic bilirubin uridine diphosphate glucuronyl transferase and uridine diphosphate glucose dehydrogenase activity in the human fetus. Pediatr Res. 1978;12(8):838\u201340. https:\/\/doi.org\/10.1203\/00006450-197808000-00007.","journal-title":"Pediatr Res."},{"issue":"2","key":"861_CR36","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1016\/j.pharmthera.2008.02.005","volume":"118","author":"RN Hines","year":"2008","unstructured":"Hines RN. The ontogeny of drug metabolism enzymes and implications for adverse drug events. Pharmacol Ther. 2008;118(2):250\u201367. https:\/\/doi.org\/10.1016\/j.pharmthera.2008.02.005.","journal-title":"Pharmacol Ther."},{"issue":"3","key":"861_CR37","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1080\/00498250110043481","volume":"31","author":"M Vietri","year":"2001","unstructured":"Vietri M, Pietrabissa A, Mosca F, Rane A, Pacific GM. Human adult and foetal liver sulphotransferases: inhibition by mefenamic acid and salicylic acid. Xenobiotica. 2001;31(3):153\u201361. https:\/\/doi.org\/10.1080\/00498250110043481.","journal-title":"Xenobiotica."},{"issue":"6","key":"861_CR38","doi-asserted-by":"publisher","first-page":"2734","DOI":"10.1210\/jcem.86.6.7569","volume":"86","author":"K Richard","year":"2001","unstructured":"Richard K, Hume R, Kaptein E, Stanley EL, Visser TJ, Coughtrie MW. Sulfation of thyroid hormone and dopamine during human development: ontogeny of phenol sulfotransferases and arylsulfatase in liver, lung, and brain. J Clin Endocrinol Metab. 2001;86(6):2734\u201342. https:\/\/doi.org\/10.1210\/jcem.86.6.7569.","journal-title":"J Clin Endocrinol Metab."},{"issue":"3","key":"861_CR39","doi-asserted-by":"publisher","first-page":"1310","DOI":"10.1124\/jpet.105.093633","volume":"316","author":"Z Duanmu","year":"2006","unstructured":"Duanmu Z, Weckle A, Koukouritaki SB, Hines RN, Falany JL, Falany CN, et al. Developmental expression of aryl, estrogen, and hydroxysteroid sulfotransferases in pre- and postnatal human liver. J Pharmacol Exp Ther. 2006;316(3):1310\u20137. https:\/\/doi.org\/10.1124\/jpet.105.093633.","journal-title":"J Pharmacol Exp Ther."},{"issue":"2","key":"861_CR40","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1159\/000480563","volume":"16","author":"M Cappiello","year":"1991","unstructured":"Cappiello M, Giuliani L, Rane A, Pacifici GM. Dopamine sulphotransferase is better developed than p-nitrophenol sulphotransferase in the human fetus. Dev Pharmacol Ther. 1991;16(2):83\u20138.","journal-title":"Dev Pharmacol Ther."},{"issue":"3","key":"861_CR41","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1016\/S0163-7258(99)00046-7","volume":"84","author":"JA Ring","year":"1999","unstructured":"Ring JA, Ghabrial H, Ching MS, Smallwood RA, Morgan DJ. Fetal hepatic drug elimination. Pharmacol Ther. 1999;84(3):429\u201345.","journal-title":"Pharmacol Ther."},{"issue":"1","key":"861_CR42","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1124\/jpet.102.053124","volume":"307","author":"EK Johnsrud","year":"2003","unstructured":"Johnsrud EK, Koukouritaki SB, Divakaran K, Brunengraber LL, Hines RN, McCarver DG. Human hepatic CYP2E1 expression during development. J Pharmacol Exp Ther. 2003;307(1):402\u20137. https:\/\/doi.org\/10.1124\/jpet.102.053124.","journal-title":"J Pharmacol Exp Ther."},{"key":"861_CR43","unstructured":"University Hospital, Gasthuisberg. Transplacental transfer of drugs used in pregnant women [ClinicalTrials.gov identifier NCT02622802]. National Institutes of Health, ClinicalTrials.gov. https:\/\/clinicaltrials.gov. Accessed 14 Jan 2020."},{"issue":"5","key":"861_CR44","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1124\/dmd.106.013029","volume":"35","author":"K Shintaku","year":"2007","unstructured":"Shintaku K, Arima Y, Dan Y, Takeda T, Kogushi K, Tsujimoto M, et al. Kinetic analysis of the transport of salicylic acid, a nonsteroidal anti-inflammatory drug, across human placenta. Drug Metab Dispos. 2007;35(5):772\u20138. https:\/\/doi.org\/10.1124\/dmd.106.013029.","journal-title":"Drug Metab Dispos."},{"issue":"2","key":"861_CR45","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1002\/psp4.12161","volume":"6","author":"TH Nguyen","year":"2017","unstructured":"Nguyen TH, Mouksassi MS, Holford N, Al-Huniti N, Freedman I, Hooker AC, et al. Model evaluation of continuous data pharmacometric models: metrics and graphics. CPT Pharmacomet Syst Pharmacol. 2017;6(2):87\u2013109. https:\/\/doi.org\/10.1002\/psp4.12161.","journal-title":"CPT Pharmacomet Syst Pharmacol."},{"issue":"1","key":"861_CR46","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.ejpb.2006.09.006","volume":"66","author":"L Laitinen","year":"2007","unstructured":"Laitinen L, Takala E, Vuorela H, Vuorela P, Kaukonen AM, Marvola M. Anthranoid laxatives influence the absorption of poorly permeable drugs in human intestinal cell culture model (Caco-2). Eur J Pharm Biopharm. 2007;66(1):135\u201345. https:\/\/doi.org\/10.1016\/j.ejpb.2006.09.006.","journal-title":"Eur J Pharm Biopharm."},{"issue":"1\u20132","key":"861_CR47","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1016\/j.ijpharm.2010.12.029","volume":"417","author":"S Khan","year":"2011","unstructured":"Khan S, Elshaer A, Rahman AS, Hanson P, Perrie Y, Mohammed AR. Systems biology approach to study permeability of paracetamol and its solid dispersion. Int J Pharm. 2011;417(1\u20132):272\u20139. https:\/\/doi.org\/10.1016\/j.ijpharm.2010.12.029.","journal-title":"Int J Pharm."},{"issue":"3","key":"861_CR48","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/S0928-0987(00)00076-2","volume":"10","author":"S Yamashita","year":"2000","unstructured":"Yamashita S, Furubayashi T, Kataoka M, Sakane T, Sezaki H, Tokuda H. Optimized conditions for prediction of intestinal drug permeability using Caco-2 cells. Eur J Pharm Sci. 2000;10(3):195\u2013204.","journal-title":"Eur J Pharm Sci."},{"issue":"1\u20132","key":"861_CR49","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/S0378-5173(03)00372-7","volume":"263","author":"F Faassen","year":"2003","unstructured":"Faassen F, Vogel G, Spanings H, Vromans H. Caco-2 permeability, P-glycoprotein transport ratios and brain penetration of heterocyclic drugs. Int J Pharm. 2003;263(1\u20132):113\u201322.","journal-title":"Int J Pharm."},{"issue":"2","key":"861_CR50","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.abb.2004.03.023","volume":"425","author":"P Tammela","year":"2004","unstructured":"Tammela P, Laitinen L, Galkin A, Wennberg T, Heczko R, Vuorela H, et al. Permeability characteristics and membrane affinity of flavonoids and alkyl gallates in Caco-2 cells and in phospholipid vesicles. Arch Biochem Biophys. 2004;425(2):193\u20139. https:\/\/doi.org\/10.1016\/j.abb.2004.03.023.","journal-title":"Arch Biochem Biophys."},{"issue":"11","key":"861_CR51","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1007\/s40262-017-0539-z","volume":"56","author":"A Dallmann","year":"2017","unstructured":"Dallmann A, Ince I, Meyer M, Willmann S, Eissing T, Hempel G. Gestation-specific changes in the anatomy and physiology of healthy pregnant women: an extended repository of model parameters for physiologically based pharmacokinetic modeling in pregnancy. Clin Pharmacokinet. 2017;56(11):1303\u201330. https:\/\/doi.org\/10.1007\/s40262-017-0539-z.","journal-title":"Clin Pharmacokinet."},{"issue":"3","key":"861_CR52","first-page":"267","volume":"23","author":"RG Robertson","year":"1986","unstructured":"Robertson RG, Van Cleave BL, Collins JJ Jr. Acetaminophen overdose in the second trimester of pregnancy. J Fam Pract. 1986;23(3):267\u20138.","journal-title":"J Fam Pract."},{"issue":"6","key":"861_CR53","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1007\/s40262-017-0583-8","volume":"57","author":"S Schalkwijk","year":"2018","unstructured":"Schalkwijk S, Buaben AO, Freriksen JJM, Colbers AP, Burger DM, Greupink R, et al. Prediction of fetal darunavir exposure by integrating human ex-vivo placental transfer and physiologically based pharmacokinetic modeling. Clin Pharmacokinet. 2018;57(6):705\u201316. https:\/\/doi.org\/10.1007\/s40262-017-0583-8.","journal-title":"Clin Pharmacokinet."},{"issue":"2","key":"861_CR54","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1002\/jcph.1515","volume":"60","author":"XI Liu","year":"2020","unstructured":"Liu XI, Momper JD, Rakhmanina N, van den Anker JN, Green DJ, Burckart GJ, et al. Physiologically based pharmacokinetic models to predict maternal pharmacokinetics and fetal exposure to emtricitabine and acyclovir. J Clin Pharmacol. 2020;60(2):240\u201355. https:\/\/doi.org\/10.1002\/jcph.1515.","journal-title":"J Clin Pharmacol."},{"issue":"10","key":"861_CR55","doi-asserted-by":"publisher","first-page":"782","DOI":"10.5414\/cp202532","volume":"54","author":"S Tanaka","year":"2016","unstructured":"Tanaka S, Hori S, Satoh H, Sawada Y. Prediction of fetal ductus arteriosus constriction by systemic and local dermatological formulations of NSAIDs based on PK\/PD analysis. Int J Clin Pharmacol Ther. 2016;54(10):782\u201394. https:\/\/doi.org\/10.5414\/cp202532.","journal-title":"Int J Clin Pharmacol Ther."},{"issue":"5","key":"861_CR56","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1248\/yakushi.123.369","volume":"123","author":"M Nishimura","year":"2003","unstructured":"Nishimura M, Yaguti H, Yoshitsugu H, Naito S, Satoh T. Tissue distribution of mRNA expression of human cytochrome P450 isoforms assessed by high-sensitivity real-time reverse transcription PCR. Yakugaku Zasshi. 2003;123(5):369\u201375. https:\/\/doi.org\/10.1248\/yakushi.123.369.","journal-title":"Yakugaku Zasshi."},{"issue":"1","key":"861_CR57","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.abb.2005.02.001","volume":"436","author":"D Choudhary","year":"2005","unstructured":"Choudhary D, Jansson I, Stoilov I, Sarfarazi M, Schenkman JB. Expression patterns of mouse and human CYP orthologs (families 1\u20134) during development and in different adult tissues. Arch Biochem Biophys. 2005;436(1):50\u201361. https:\/\/doi.org\/10.1016\/j.abb.2005.02.001.","journal-title":"Arch Biochem Biophys."},{"issue":"2","key":"861_CR58","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1111\/j.1432-1033.1996.0476z.x","volume":"238","author":"I Vieira","year":"1996","unstructured":"Vieira I, Sonnier M, Cresteil T. Developmental expression of CYP2E1 in the human liver. Hypermethylation control of gene expression during the neonatal period. Eur J Biochem. 1996;238(2):476\u201383.","journal-title":"Eur J Biochem."},{"issue":"8","key":"861_CR59","doi-asserted-by":"publisher","first-page":"487","DOI":"10.2165\/00003088-200443080-00001","volume":"43","author":"MR Syme","year":"2004","unstructured":"Syme MR, Paxton JW, Keelan JA. Drug transfer and metabolism by the human placenta. Clin Pharmacokinet. 2004;43(8):487\u2013514. https:\/\/doi.org\/10.2165\/00003088-200443080-00001.","journal-title":"Clin Pharmacokinet."},{"issue":"3","key":"861_CR60","first-page":"145","volume":"4","author":"UW Weigand","year":"1984","unstructured":"Weigand UW, Chou RC, Maulik D, Levy G. Assessment of biotransformation during transfer of propoxyphene and acetaminophen across the isolated perfused human placenta. Pediatr Pharmacol (New York). 1984;4(3):145\u201353.","journal-title":"Pediatr Pharmacol (New York)."}],"container-title":["Clinical Pharmacokinetics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40262-020-00861-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40262-020-00861-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40262-020-00861-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,2,11]],"date-time":"2021-02-11T14:59:05Z","timestamp":1613055545000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40262-020-00861-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2,12]]},"references-count":60,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2020,7]]}},"alternative-id":["861"],"URL":"https:\/\/doi.org\/10.1007\/s40262-020-00861-7","relation":{},"ISSN":["0312-5963","1179-1926"],"issn-type":[{"value":"0312-5963","type":"print"},{"value":"1179-1926","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,2,12]]},"assertion":[{"value":"12 February 2020","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"For this project, P. Mian was supported by the Sophia Stichting Wetenschappelijk Onderzoek (SSWO) (S16-08) and received a Short Term Minor (STM-2017) Grant from the Stichting Sophia Kinderziekenhuis to conduct this research, a travel grant from Eramus Trustfonds, and the Dr. Catharine van Tussenbroek, Mevr. Speleers Pharmacy grant.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"Paola Mian, Karel Allegaert, Sigrid Conings, Pieter Annaert, Dick Tibboel, Marc Pfister, Kristel van Calsteren, and John van den Anker have no conflicts of interest directly related to this study. Andr\u00e9 Dallmann is an employee of Bayer AG, a company which is part of the Open Systems Pharmacology (OSP) member team and involved in OSP software development.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}